Contact us to discuss the most suitable alternative PROTAC strategy for your target and project stage
Submit Inquiry* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
BOC Sciences provides integrated support for alternative PROTAC technology development to help clients address targets and research questions that are difficult to solve through standard degrader formats alone. Our services are designed for pharmaceutical companies, biotechnology innovators, academic laboratories, and research platforms seeking more flexible degradation solutions for challenging protein classes, limited-ligand targets, nucleic acid-binding proteins, and spatiotemporally controlled degradation studies.
We focus on technically differentiated degrader strategies tailored to challenging targets, unconventional binding modes, and specialized research objectives. From target feasibility assessment and degrader concept selection to construct design, synthesis, degradation validation, and iterative optimization, we help clients reduce technical uncertainty and generate development-ready research data with greater efficiency.
BOC Sciences provides CLIPTAC (Click-formed Proteolysis Targeting Chimera) technology development services for clients seeking modular protein degradation strategies with improved design flexibility and intracellular assembly potential. By leveraging bioorthogonal click chemistry to assemble degrader components in situ, we help reduce the design burden associated with large preassembled bifunctional molecules while enabling flexible exploration of target ligand and E3 ligand combinations.
We support oligonucleotide-based PROTAC development for projects aimed at degrading DNA-binding or RNA-binding proteins that are difficult to address through conventional small-molecule ligand discovery. By integrating sequence-specific oligonucleotide recognition elements with degradation-recruiting modules, we help clients build targeted degradation tools for transcription factors, nucleic acid-associated regulators, and other challenging protein classes.
BOC Sciences offers RNA-PROTAC technology development services to help clients target RNA-binding proteins through RNA-derived or RNA-mimicking recognition elements linked to protein degradation modules. This strategy is especially valuable for targets whose biological function relies on RNA recognition and where traditional ligand discovery remains limited.
We provide light-controllable PROTAC technology development services for clients interested in achieving spatiotemporal control of protein degradation. By incorporating photoswitchable or photocaged elements into degrader design, we help enable controllable target degradation in response to light, supporting mechanism studies, precise biological interrogation, and advanced tool compound development.
Have You Encountered These Challenges in Alternative PROTAC Development?
Tell Us Your Challenge
Contact us to discuss the most suitable alternative PROTAC strategy for your target and project stage
Submit InquiryTo help clients move beyond standard degrader approaches, we provide integrated solutions tailored to challenging targets, unconventional binding modes, and modality-specific development needs.
Some targets remain difficult to access through conventional warhead discovery. We address this by evaluating alternative recognition strategies such as oligonucleotide-guided binding, RNA-derived recognition elements, and modular click-assembled degrader concepts, helping clients define more realistic target-entry solutions from the beginning.
Alternative degrader projects often require careful balancing of recognition element design, linker architecture, conjugation chemistry, and degradation performance. We support systematic construct design and prioritization to help clients generate candidates with better mechanistic fit and clearer optimization potential.
It is not enough to observe target signal reduction. We help clients verify true degradation behavior through appropriately designed cell-based assays, pathway-relevant controls, dose-response analysis, and functional readouts so that project decisions are based on interpretable data rather than ambiguous activity.
For projects requiring controllable degradation windows, reversible activation, or better temporal resolution, we support light-responsive degrader design and validation workflows. This helps clients investigate target biology more precisely and gain higher-value mechanistic insight from degradation-based studies.
Choose BOC Sciences to explore more flexible and innovative degrader strategies
We help clients identify, design, and validate alternative PROTAC technologies that better match target biology, project goals, and research complexity.
Academic and research teams often focus on new biological mechanisms, difficult protein classes, and exploratory degradation concepts. We provide flexible support from target assessment to construct design and validation to help generate high-value mechanistic data and accelerate research progress.
Biotech companies need practical solutions to turn novel ideas into actionable data under tight timelines and resource constraints. Our alternative degrader development services help these clients evaluate feasibility faster, prioritize workable constructs, and build stronger early-stage programs.
Pharmaceutical teams often seek new degradation routes for protein classes that remain challenging under standard design logic. We support discovery and optimization efforts by providing customized alternative PROTAC workflows aligned with specific target biology and portfolio goals.
CROs and technical service groups may need specialized degrader capabilities beyond conventional chemistry and screening support. We offer modular service components that strengthen project execution and help partners respond to more technically demanding client needs.
Inquiry and Requirement Collection
Understand the client's target class, research objective, technical questions, preferred modality direction, timeline, and data expectations.
Target Feasibility and Strategy Assessment
Evaluate target tractability, recognition options, degrader route suitability, and project risks to define the most appropriate alternative PROTAC strategy.
Construct Concept Design
Design the recognition module, degradation-recruiting element, linker or conjugation logic, and control constructs based on the selected technical route.
Proposal Finalization and Project Launch
Define the scope of work, deliverables, and technical milestones, then initiate the project with background data integration and execution planning.
Synthesis and Build Preparation
Prepare candidate constructs, modules, or analog series and complete required analytical confirmation before biological testing.
Degradation and Functional Validation
Assess degradation efficiency, target response, selectivity, and biological relevance using fit-for-purpose in vitro and cell-based assays.
Optimization Iteration
Refine construct design based on activity data, mechanism findings, and structure-function relationships to improve degradation performance.
Data Reporting and Candidate Recommendation
Deliver project data, prioritized constructs, and clear interpretation to support the client's next-stage research and development decisions.
Alternative PROTAC technologies can provide useful solutions for protein classes that are difficult to address through standard bifunctional degrader design.
By incorporating nucleic acid-guided recognition, modular click assembly, or light-responsive control elements, these approaches offer greater design flexibility for complex biological questions.
Certain alternative formats, especially light-controllable systems, help researchers study protein function with improved temporal and experimental control.
When traditional design logic reaches limitations, alternative degrader strategies can open new opportunities for target validation and candidate exploration.

Project Background
A biotechnology company was investigating the transcription factor c-Myc, a DNA-binding protein with strong disease relevance but limited tractability in conventional ligand discovery. The client wanted to explore whether an oligonucleotide-guided degradation strategy could provide a more effective route for target engagement and degradation validation.
Our Support
We first assessed c-Myc's DNA recognition behavior, protein function, and the feasibility of sequence-guided degrader design. Based on this analysis, we proposed an oligonucleotide PROTAC architecture consisting of a c-Myc-binding double-stranded DNA motif, a flexible linker, and an E3 ligase-recruiting ligand. We then designed multiple candidate constructs with different oligonucleotide motifs, conjugation positions, and degradation-recruiting modules. After screening and iterative optimization, we generated 16 constructs and identified 3 with reproducible target reduction in cell-based assays. Among them, the top candidate showed clear dose dependence, better degradation consistency, and a more favorable signal window than the initial construct series, giving the client a practical foundation for further optimization.
Client Testimonial
BOC Sciences helped us convert a difficult target concept into a workable degradation strategy. Their support in feasibility analysis, construct design, and assay validation gave us a much clearer path forward.
Project Background
An academic research team needed a light-responsive degrader tool to study the time-dependent function of STAT3, a signaling protein involved in rapid cellular response pathways. The main challenge was achieving controllable degradation activation while maintaining measurable degradation performance and experimental interpretability.
Our Support
We designed a light-controllable PROTAC workflow and prioritized a photocaged architecture combining a STAT3-binding warhead, an E3 ligase ligand, and a light-cleavable caging group that suppressed activity before irradiation. The project included degrader design, synthesis of a focused candidate set, optimization of 365 nm LED irradiation at 5 mW/cm² for 60 seconds, and validation in cell-based degradation assays. We prepared 12 candidate molecules and identified 2 leads that showed low background activity in the dark, with an activation threshold defined as >50% STAT3 degradation after light exposure but<15% in dark controls. This enabled the client to establish a more precise time-resolved degradation study system for downstream biological investigation.
Client Testimonial
The BOC Sciences team provided exactly the kind of technical depth we needed for a specialized degrader tool project. Their ability to connect design logic with practical validation was especially valuable.
Experience in Specialized Degrader Formats
We support multiple alternative PROTAC approaches and help clients choose technically appropriate strategies for difficult targets and complex research goals.

Mechanism-Oriented Development Logic
We design projects around target biology, binding mode, degradation rationale, and validation strategy rather than relying on generic degrader templates.
Integrated Design, Synthesis, and Validation Support
Our services cover the full workflow from feasibility analysis and construct generation to biological testing and optimization.
Flexible Solutions for Challenging Targets
We help clients build practical degradation strategies for protein classes that are difficult to address through standard discovery routes.
High-Value Research Data and Clear Decision Support
We provide structured data and actionable interpretation to help clients move from exploratory concept to confident next-step planning.
Efficient Project Communication and Execution
Through coordinated technical planning and responsive project support, we help clients reduce uncertainty and improve development efficiency.
Alternative PROTAC technologies offer broader modality coverage than conventional bifunctional degraders because they are not restricted to one degradation mechanism or one target class. Platforms such as molecular glues, LYTACs, AUTACs, ATTECs, and RIBOTACs can be adapted for intracellular proteins, membrane proteins, extracellular targets, and even RNA-related pathways. For drug discovery teams, this creates more flexibility in hit identification, mechanism-driven design, and target selection, especially when traditional inhibition approaches are insufficient. At BOC Sciences, we support clients with strategy assessment, molecular design planning, and target-oriented development workflows to help identify the most suitable alternative degradation platform for each program.
Alternative PROTAC approaches are often better suited for targets that are difficult to address with traditional small-molecule inhibitors or classic PROTAC architectures. These may include membrane-associated proteins, secreted proteins, extracellular disease mediators, aggregation-related targets, and RNA-linked disease drivers. The key question in development is not simply whether a target can be degraded, but which biological clearance or degradation pathway best matches the target’s localization and mechanism. BOC Sciences can help evaluate target class, ligand accessibility, and mechanistic fit, enabling clients to prioritize alternative PROTAC formats with stronger scientific rationale and better downstream development potential.
The main design challenges in alternative PROTAC molecules usually involve achieving the right balance between target recognition, pathway engagement, and molecular architecture. A successful molecule must not only bind the intended target, but also recruit or activate the appropriate degradation, trafficking, or clearance mechanism in a biologically relevant context. Problems often arise from suboptimal linker design, poor spatial arrangement, insufficient cellular uptake, or weak compatibility with the intended degradation route. As a result, alternative PROTAC development requires integrated optimization across chemistry, molecular biology, and functional testing rather than a purely synthetic approach.
Early feasibility evaluation for alternative PROTAC development should begin with a structured review of target biology, ligand availability, degradation pathway relevance, and assay readiness. Teams need to understand where the target is located, whether an appropriate recognition element exists, and whether the selected degradation or clearance pathway is active in the intended cellular system. It is equally important to establish functional assays that can confirm key events such as target engagement, internalization, degradation, or pathway activation. BOC Sciences provides early-stage support covering technical route assessment, molecular design guidance, and customized development planning to help clients reduce uncertainty before larger resource commitments are made.
When selecting an alternative PROTAC service partner, clients should look beyond synthetic capability alone and focus on platform understanding, cross-disciplinary integration, and problem-solving experience across different degrader modalities. A strong partner should be able to connect target biology, ligand strategy, molecular format selection, and functional validation into a coherent development path. This is especially important in alternative PROTAC projects, where success often depends on choosing the right mechanism rather than simply making the molecule. For drug discovery teams seeking efficient and credible external support, a partner with broad technical coverage and target-specific development experience can significantly improve project confidence and execution quality.
Please contact us with any specific requirements and we will get back to you as soon as possible.